Opus Genetics, Inc.
Income Statement
| Line Item | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | $100.0K |
| Gross Profit | — | — | — | $-100.0K |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | $3.4M | $12.0M | $3.9M | $3.2M |
| SG&A Expense | $2.7M | $3.5M | $6.0M | $2.9M |
| Operating Income | $-6.6M | $-16.1M | $-10.3M | $-6.5M |
| Operating Margin | — | — | — | — |
| Interest Expense | — | — | — | — |
| Pretax Income | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $-6.2M | $-11.3M | $-14.0M | $-2.9M |
| Net Margin | — | — | — | — |
| EPS (Basic) | $-0.01 | $-0.02 | $-0.03 | $-0.01 |
| EPS (Diluted) | $-0.01 | $-0.02 | $-0.03 | $-0.01 |
| Shares Outstanding (Basic) | 716.6M | 572.1M | 505.0M | — |
| Shares Outstanding (Diluted) | 716.6M | 572.1M | 505.0M | — |
| Dividends Per Share | — | — | — | — |